4.8 Article

Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behcet's disease

Publisher

NATL ACAD SCIENCES
DOI: 10.1073/pnas.2204289119

Keywords

Behcet's disease; single-cell analysis; monocytes; interferon

Funding

  1. National Natural Science Foundation of China [82171800, 81871299, 82030017]
  2. National Key Research and Development Project of China [2019YFA0801500, 2020YFC2008003]
  3. Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [2021-1-I2M-050, 2019-RC-HL-006]

Ask authors/readers for more resources

This study provides insights into the immune landscape of Behcet's disease (BD) and highlights the contribution of C1q-high (C1q(hi)) monocytes to BD hyperinflammation. C1q(hi) monocytes demonstrate increased phagocytosis and proinflammatory cytokine secretion, and their presence is clinically relevant. Activated interferon-gamma (IFN-gamma) signaling induces the accumulation of C1q(hi) monocytes, which can be reduced by tofacitinib treatment.
Behcet's disease (BD) is a chronic vasculitis characterized by systemic immune aberrations. However, a comprehensive understanding of immune disturbances in BD and how they contribute to BD pathogenesis is lacking. Here, we performed single-cell and bulk RNA sequencing to profile peripheral blood mononuclear cells (PBMCs) and isolated monocytes from BD patients and healthy donors. We observed prominent expansion and transcriptional changes in monocytes in PBMCs from BD patients. Deciphering the monocyte heterogeneity revealed the accumulation of C1q-high (C1q(hi)) monocytes in BD. Pseudotime inference indicated that BD monocytes markedly shifted their differentiation toward inflammation-accompanied and C1q(hi) monocyte-ended trajectory. Further experiments showed that C1q(hi) monocytes enhanced phagocytosis and proinflammatory cytokine secretion, and multiplatform analyses revealed the significant clinical relevance of this subtype. Mechanistically, C1q(hi) monocytes were induced by activated interferon-gamma (IFN-gamma) signaling in BD patients and were decreased by tofacitinib treatment. Our study illustrates the BD immune landscape and the unrecognized contribution of C1q(hi) monocytes to BD hyperinflarnmation, showing their potential as therapeutic targets and clinical assessment indexes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available